profit from every ₹100 of sales.
₹0₹100
Global Health
₹1,429.00+0.13% today
+24.5% in 1 year
1-year low ₹961.101-year high ₹1,508.90
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2023 to 2026.
0%20% a year
You pay ₹68.96 for every ₹1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Global Health sold, what it kept, and what it did with the cash.
Sales went from ₹26.8 billion in 2023 to ₹44.1 billion in 2026, with ₹5.56 billion of profit last year.
SalesProfit
Global Health vs. similar companies
Global Health grows in the middle of these 5 and is the most expensive for its profits.
| Company | Profit from ₹100 of sales | Sales growth a year | Price per ₹1 of profit |
|---|---|---|---|
| Global Health | 69.0× · Very expensive | ||
 HCA Healthcare | 15.6× · Fair price | ||
 Fresenius SE & Co. KGaA | 23.5× · Fair price | ||
 IHH Healthcare Berhad | 33.4× · Expensive | ||
 Rede D'Or São Luiz | 15.9× · Fair price |
AI analysis
An AI analyst reads Global Health's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| 26,828 | 32,409 | 36,923 | 44,103 | |
| 20,575 | 24,816 | 28,127 | 34,135 | |
| 4,991 | 6,583 | 6,835 | 6,966 | |
| 6,767 | 8,724 | 9,063 | 10,167 | |
| 3,261 | 4,782 | 4,814 | 5,565 | |
| 12.57 | 17.80 | 17.92 | – | |
| 76.7% | 76.6% | 76.2% | 77.4% | |
| 18.6% | 20.3% | 18.5% | 15.8% | |
| 12.2% | 14.8% | 13.0% | 12.6% |
Balance sheet
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Total assets | 41,160 | 43,041 | 47,662 | 59,050 |
| Cash | 7,672 | 4,246 | 2,302 | 1,273 |
| Total debt | 11,220 | 8,019 | 7,177 | 11,900 |
| Total liabilities | 16,878 | 13,985 | 13,787 | 19,207 |
| 24,282 | 29,056 | 33,864 | 39,616 | |
| 259 | 269 | 269 | – | |
| 11.1% | 14.2% | 13.0% | 11.6% | |
| 13.4% | 16.5% | 14.2% | 14.0% |
Cash flow
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| 6,445 | 6,121 | 6,238 | 7,144 | |
| 2,360 | 2,786 | 6,479 | 9,786 | |
| 4,085 | 3,335 | -242 | -2,642 | |
| Dividends paid | – | – | – | 134 |
| – | – | 0 | 98 | |
| 7 | 2 | 0 | 383 |
Valuation
- 69.0×
- –
- –
- 8.3×
- 8.7×
- –
- 38.8×
- -0.7%
- 1.5%
- 0.0%
Profitability
- 77.4%
- 15.8%
- 12.6%
- –
- 11.6%
- 12.5%
- –
- –
- –
- –
Growth
- +18.0%
- –
- –
- –
- +1.9%
Financial health
- 1.0×
- 0.30
- –
- 10.0×
- 2.67
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 22%of 958
Top 33%of 888
Bottom 16%of 600
Top 31%of 889
Bottom 34%of 987
0.0%of the share price, paid each year
On $1,000 invested$0a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
2.4% of its profit
Room to growStretchedMore than it earnsNews
Gabelli Global Utility & Income Trust declares $0.11 dividendSeeking Alpha · Nov 11, 2026Global High-Performance Computing (HPC) Application-Specific Integrated Circuit (ASIC) Market Report 2026-2030Yahoo Finance · Nov 10, 2026iShares Global Tech ETF (IXN) Sells $26.8 Million of Apple on Nov. 6Yahoo Finance · Nov 10, 2026Global Ship Lease raises dividend by 10% to $0.6875Seeking Alpha · Nov 10, 2026Microsoft (MSFT) Signs Global AI Safety DeclarationYahoo Finance · Nov 10, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
48No pass
Benjamin Graham
42No pass
Philip Fisher
47No pass
Peter Lynch
77Pass
Joel Greenblatt
8No pass
Charlie Munger
39No pass
Terry Smith
33No pass
Questions about Global Health
Is Global Health a good stock to buy?
A solid business, priced as if everything goes right. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Global Health AI analysis
What does Global Health do?
Global Health Limited, together with its subsidiaries, provides healthcare services in India. It is in Medical Care Facilities, based in Gurugram, India.
Does Global Health pay a dividend?
Yes. At today's price the dividend is 0.0% a year, about 2% of its yearly profit. In 2026 it paid out ₹134 million in dividends.
Is Global Health stock halal?
Yes. Global Health passes our halal screen: its business is permitted and its debt is 3% of its market value, under the 30% limit. How we check
How has Global Health stock done over the past year?
Up 24.5% over the past twelve months, to ₹1,429.00. It traded between ₹961.10 and ₹1,508.90 and is 5.3% below its high.
Who are Global Health's competitors?
The largest listed companies in the same industry are HCA Healthcare, Fresenius SE & Co. KGaA, IHH Healthcare Berhad and Rede D'Or São Luiz. The peers table on this page compares their profit, growth and price with Global Health's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.